publication venue for
- Sustained expression of coagulation factor IX by modified cord blood‐derived mesenchymal stromal cells. 16:131-142. 2014
- Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell‐independent protective immunity. 12:693-704. 2010
- Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice. 9:1002-1010. 2007
- A convenient plasmid system for construction of helper‐dependent adenoviral vectors and its application for analysis of the breast‐cancer‐specific mammaglobin promoter. 8:442-451. 2006
- Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells. 8:362-369. 2006
- Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts. 7:1482-1491. 2005
- Use of a murine secreted alkaline phosphatase as a non‐immunogenic reporter gene in mice. 7:307-315. 2005
- Heterogeneity of the immune response to adenovirus‐mediated factor VIII gene therapy in different inbred hemophilic mouse strains. 6:1358-1368. 2004
- Therapeutic levels of human Factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A. 4:215-223. 2002
- Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor. 2:279-288. 2000